Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Predictive Factors and Outcome in Medical Thoracoscopy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02288065
Recruitment Status : Completed
First Posted : November 11, 2014
Last Update Posted : December 30, 2016
Sponsor:
Information provided by (Responsible Party):
Yserbyt Jonas, KU Leuven

Brief Summary:
Retrospective survey for factors predicting the outcome of medical thoracoscopy

Condition or disease Intervention/treatment
Pleuritis Drug: sterile talc pleurodesis

Detailed Description:
Retrospective survey for factors predicting the outcome of medical thoracoscopy in patients with malignant pleuritis

Layout table for study information
Study Type : Observational
Actual Enrollment : 155 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Predictive Factors and Outcome in Medical Thoracoscopy
Study Start Date : January 2014
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016

Group/Cohort Intervention/treatment
responders
amelioration of dyspnea radiological amelioration after sterile talc pleurodesis
Drug: sterile talc pleurodesis
medical thoracoscopy and talc pleurodesis. No specific device is studied.
Other Name: medical thoracoscopy

failed intervention
unchanged symptoms and radiology after sterile talc pleurodesis
Drug: sterile talc pleurodesis
medical thoracoscopy and talc pleurodesis. No specific device is studied.
Other Name: medical thoracoscopy




Primary Outcome Measures :
  1. Chest X-ray [ Time Frame: 3 months ]
    radiological resolution of pleuritis; 3 level severity grading (A, B, C, with C as worst grade)


Secondary Outcome Measures :
  1. time interval [ Time Frame: 12 months ]
    survival in months



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
pulmonary or extrathoracic malignancy
Criteria

Inclusion Criteria:

  • progressive malignancy
  • pleuritis

Exclusion Criteria:

  • respiratory failure
  • unable to consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02288065


Locations
Layout table for location information
Belgium
UZ Leuven
Leuven, Belgium, 3000
Sponsors and Collaborators
KU Leuven
Investigators
Layout table for investigator information
Principal Investigator: Jonas Yserbyt UZ Leuven

Layout table for additonal information
Responsible Party: Yserbyt Jonas, MD, KU Leuven
ClinicalTrials.gov Identifier: NCT02288065     History of Changes
Other Study ID Numbers: S561430
First Posted: November 11, 2014    Key Record Dates
Last Update Posted: December 30, 2016
Last Verified: December 2016
Additional relevant MeSH terms:
Layout table for MeSH terms
Pleurisy
Pleural Diseases
Respiratory Tract Diseases
Respiratory Tract Infections